FIELD: medicine.
SUBSTANCE: the suggested preparation is a molecular complex of free foundation of fluoxetine and glycyrrisinic acid at the following ratio of components: free foundation of fluoxetine : glycyrrisinic acid being 1 : (1 - 4).
EFFECT: higher efficiency.
2 dwg, 9 ex, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
GLYCYRRHIZIC ACID TRIAMIDE WITH 4-PHENYL-2-AMINOTHIAZOLE SHOWING ANTIDEPRESSANT ACTIVITY | 1990 |
|
SU1764303A1 |
0 |
|
SU1781225A1 | |
GLYCYRRHIZIC ACID TRIAMIDE WITH 3-AMINOQUINOLINE SHOWING ANTIDEPRESSANT ACTIVITY | 1990 |
|
SU1764302A1 |
BENZOGONTATHIEPIN DERIVATIVE OF ANTICONVULSANT AND ANTIANXIOUS ACTIVITY | 2007 |
|
RU2341521C1 |
ANTICONVULSIVE MEDICATION | 2007 |
|
RU2355390C1 |
β-GLYCYRRHIZIC ACID GLYCOPEPTIDE WITH L-GLUTAMIC ACID DIBUTYL ETHER SHOWING ANTIINFLAMMATORY AND ANTIULCER ACTIVITY | 1991 |
|
RU2024548C1 |
AMIDE β GLYCIRRHIZIC ACID WITH PHENYLBORON ACID SHOWING ANTIINFLAMMATORY AND ANTIULCEROUS ACTIVITY | 1991 |
|
RU2032694C1 |
GLYCOPEPTIDE OF β-GLYCYRRHIZIC ACID WITH L-PHENYLALANINE METHYL ESTER SHOWING ANTIINFLAMMATORY AND ANTIULCEROUS ACTIVITIES | 1990 |
|
SU1777333A1 |
5H-3,4,6,7 -TETRAHYDRO -10-METHOXY -5-METHYL -6-(1',1'-DIOXIDO-3'- META-CHLOROANILINO -4'- METHOXYBENZO [B]THIOPHENE -7'-YL)-FURO [- 4,3,2 -Q][3]BENZAZOCINE SHOWING ANTIDEPRESSANT ACTION | 1991 |
|
RU2024526C1 |
β-GLYCYRRHIZIC ACID GLYCOPEPTIDE WITH L-GLUTAMIC ACID DIBUTYL ETHER SHOWING ANTI-AIDS-ACTIVITY | 1991 |
|
RU2024546C1 |
Authors
Dates
2004-07-20—Published
2002-04-05—Filed